company

NORSK HUNDETERAPI AS

2380 BRUMUNDDAL

Return on Equity
1 016,67 %
Current Ratio
3,72
Debt-to-Equity Ratio
49,83
Key figures (NOK)2022
Revenue838 000
Net Income61 000
Total Assets393 000
Total Equity6 000
Income (NOK)2022
Revenue838 000
Expenditure767 000
Operating Profit71 000
Financial Income1 000
Financial Costs2 000
Financial Balance−1 000
Earnings Before Tax70 000
Tax9 000
Net Income61 000
Balance (NOK)2022
Total Fixed Assets66 000
Total Current Assets327 000
Total Assets393 000
Total Retained Equity−24 000
Total Equity6 000
Total Long-Term Debt299 000
Total Current Debt88 000
Total Equity and Debt393 000
Cash flow (NOK)2022
Sales Income838 000
Other Income0
Revenue838 000
Cost of Goods Sold217 000
Salary Costs239 000
Depreciation52 000
Impairment0
Expenditure767 000
Operating Profit71 000
Financial Income1 000
Financial Costs2 000
Financial Balance−1 000
Dividends0
Net Income61 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities66 000
Fixtures0
Total Tangible Assets66 000
Total Fiancial Fixed Assets0
Total Fixed Assets66 000
Stock204 000
Total Investments0
Cash, Bank114 000
Total Current Assets327 000
Total Assets393 000
Total Equity6 000
Short-Term Group Debt0
Total Long-Term Debt299 000
Creditors16 000
Unpaid Taxes28 000
Dividends0
Other Current Debt25 000
Total Current Debt88 000
Total Equity and Debt393 000
Financial indicators2022
Return on Equity1 016,67 %
Debt-to-Equity Ratio49,83
Operating Profit Margin8,47 %
Current Ratio3,72
Quick Ratio−2,82
Equity Ratio0,02
Gross Profit Margin74,11 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English